Data / Drug companies / Pyrantel pamoate
Pyrantel pamoate: 13 companies and 19 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Pyrantel pamoate is listed in the FDA National Drug Code Directory by 13 companies, with 19 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are suspension; tablet; tablet, chewable, and the newest product started marketing on October 8, 2026.
The request: Get every company that lists pyrantel pamoate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 13
- Products
- 19
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Pinrid, Pinworm Treatment, Walgreens Pinworm Medicine, Pinworm Medicine, CVS Pinworm Treatment, Pinworm Medicine, Parasitol, Carrotee IverGurad
- openFDA record search
- api.fda.gov
Companies that list pyrantel pamoate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Yyba Corp | 4 | tablet; liquid | Over the counter monograph drugs | July 13, 2026 |
| Bionpharma Inc. | 2 | tablet, chewable; suspension | Over the counter monograph drugs | September 30, 2026 |
| Opmx LLC | 2 | tablet | Over the counter monograph drugs | September 24, 2025 |
| ProMex LLC | 2 | tablet; suspension | Over the counter monograph drugs | September 27, 2002 |
| Amerisource Bergen | 1 | suspension | Over the counter monograph drugs | January 21, 2026 |
| CVS Pharmacy | 1 | suspension | Over the counter monograph drugs | December 15, 2016 |
| Guangdong Jiaoyu Biotechnology Co., Ltd | 1 | tablet | Over the counter monograph drugs | October 8, 2026 |
| Jefferson Labs | 1 | suspension | Over the counter monograph drugs | November 21, 2015 |
| Menper Distributors, Inc. | 1 | suspension | Over the counter monograph drugs | January 1, 2013 |
| Pharmadel LLC | 1 | tablet | Over the counter monograph drugs | August 1, 2024 |
| Reese Pharmaceutical Co | 1 | suspension | Over the counter monograph drugs | September 28, 2022 |
| Strategic Sourcing Services LLC | 1 | suspension | Over the counter monograph drugs | December 5, 2025 |
| Walgreen Company | 1 | suspension | Over the counter monograph drugs | November 16, 2015 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Suspension | 9 | 47.4% |
| Tablet | 8 | 42.1% |
| Tablet, chewable | 1 | 5.3% |
| Liquid | 1 | 5.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 19 | 100% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.